Çi?dem KADER, Z Tu?ba ÖZDEMİR, Tekin YÖLDÖRÖM, Mehmet ÇELİKBİLEK, Adem KARA

Portal Lenfadenopati ve Kolestatik Hepatitle Seyreden Epstein Barr Virüs Enfeksiyonu

Epstein-Barr virüsü (EBV) dünyada yaygÖn bir da?ÖlÖm gösteren B lenfotropik insan herpes virüsüdür. Tükrük yo- luyla bulaLtÖ?Ö için öpücük hastalÖ?Ö olarak da bilinen enfeksiyöz mononükleoz (EM) tablosuna neden olur. EBV akut hepatitin nadir bir nedeni olup kolestatik hepatit ise EBV enfeksiyonu seyrinde çok daha nadir görülmekte- dir. Biz bu yazÖda EBV enfeksiyonuna ba?lÖ kolestatik hepatit ve portal lenfadenopati geliLen bir olguyu sunduk.

Epstein Barr Virus Infection Presenting with Portal Lymphadenopathy and Cholestatic Hepatitis

Epstein-Barr virus (EBV) is a B lymphotropic human herpes virus and have a widespread distribution in the world. It causes infectious mononucleosis (EM) which is known as the kissing disease because of transmission through saliva. EBV is a rare cause of acute hepatitis, cholestatic hepatitis in the course of the EBV infection is much more rare. In this paper, we report a case with cholestatic hepatitis and portal lymphadenopathy due to EBV infection.

PDF

___

1. Odumade OA, Hogquist KA, Balfour HH, Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clinical microbiology reviews. 2011;24:193-209.
2. Macsween KF, Crawford DH. EpsteinBarr virus-recent advances. The Lancet Infectious diseases. 2003;3:131-40.
3. Auwaerter PG. Infectious mononucleosis in middle age. Jama. 1999;281:454-459.
4. Vine LJ, Shepherd K, Hunter JG, et al. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Alimentary pharmacology & therapeutics. 2012;36:16-21.
5. Barreales M, Pérez-Carreras M, Meizoso T, et al., editors. [Epstein-Barr virus infection and acute cholestatic hepatitis]. Anales de medicina interna (Madrid, Spain: 1984); 2006.
6. Hinedi TB, Koff RS. CASE REPORT: Cholestatic Hepatitis Induced by EpsteinBarr Virus Infection in an Adult. Digestive diseases and sciences. 2003;48:539-541.
7. Fidan I, Yüksel S, ùmir T. Deøiûik yaû gruplarÖnda Epstein-Barr virus antikorlarÖnÖn araûtÖrÖlmasÖ. ùnfeksiyon Dergisi (Turkish Journal of Infection). 2005;19:453-456.
8. Jenson HB. Acute complications of Epstein-Barr virus infectious mononucleosis. Current opinion in pediatrics. 2000;12:263-268.
9. Johannsen EC, Schooley R, Kaye K. Epstein-Barr virus (infectious mononucleosis). Principles and Practice of Infectious Diseases 6th ed Philadelphia, PA: Churchill Livingstone. 2005.
10. Finkel M, Parker GW, Fanselau Ha. The HepatÖtÖs Of InfectÖous MononucleosÖs: ExperÖence WÖth 235 Cases. Military medicine. 1964;129:533-538.
11. Crum NF. Epstein Barr virus hepatitis: case series and review. Southern medical journal. 2006;99:544-547.
12. Schaade L, Meilicke R, Büttgen S, et al. [Manganese superoxide dismutaseinhibiting autoantibodies in cholestatic Epstein-Barr viral hepatitis]. Deutsche medizinische Wochenschrift (1946). 1998;123:1478-1482.
13. Vukoviy VR, Mijailoviy Z, Borovÿanin N. Epstein-Barr virus hepatitis associated with icterus: Case report. Medicinski ÿasopis. 2010;44:14-18.
14. Chalupa P, Kaspar M, Holub M. Acute acalculous cholecystitis with pericholecystitis in a patient with Epstein-Barr Virus infectious mononucleosis. Medical Science Review. 2009;15:CS30-CS3.
15. Dikici N, Ural O. EpsteÖn-Barr VÖrus'a BaølÖ Akut Kolestatik Hepatit: ùki Olgu. ùnfeksiyon Dergisi (Turkish Journal of Infection). 2009;23:197-200.
16. Rafailidis PI, Mavros MN, Kapaskelis A, et al. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2010;49:151- 157.